Singapore, Singapore

Yee Ling Evelyn Tan

USPTO Granted Patents = 7 


Average Co-Inventor Count = 7.5

ph-index = 3

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2012-2021

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Yee Ling Evelyn Tan

Introduction:

Yee Ling Evelyn Tan, a prolific inventor based in Singapore, SG, has made significant contributions in the field of pharmaceuticals with a total of 7 patents to his name. His groundbreaking work in developing oxygen-linked pyrimidine derivatives as anti-proliferative agents has positioned him as a key figure in the treatment of proliferative disorders.

Latest Patents:

Yee Ling Evelyn Tan's latest patents revolve around oxygen-linked pyrimidine compounds, which show promising potential as anti-proliferative agents. These compounds have been designed for their efficacy in treating various proliferative disorders, including tumors and cancers, as well as other conditions associated with kinases. The inventions include methods for preparation, pharmaceutical compositions, and applications in treating a range of disorders.

Career Highlights:

Throughout his career, Yee Ling Evelyn Tan has demonstrated a keen focus on developing innovative solutions for pressing medical issues. His tenure at companies like S*bio Pte Ltd and Cti Biopharma Corp. has been marked by a dedication to advancing the field of pharmaceuticals through cutting-edge research and development.

Collaborations:

Yee Ling Evelyn Tan has had the privilege of collaborating with esteemed professionals in the industry, such as Harish Kumar Mysore Nagaraj and Anders Poulsen. These collaborations have not only enriched his work but have also led to the successful realization of patents that have the potential to transform the landscape of medical treatments.

Conclusion:

Inventor Yee Ling Evelyn Tan's pioneering work in the realm of pharmaceuticals, particularly in the development of oxygen-linked pyrimidine derivatives, underscores his commitment to advancing healthcare through innovation. With a track record of 7 patents and a spirit of collaboration, he continues to be a driving force in the fight against proliferative disorders globally.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…